L’Oreal Allowed To Market Reconstructed Skin Tissue In China

L'Oréal was granted a business license in China that will allow it to market its reconstructed Asian skin models through Shanghai Episkin Biotechnology. L'Oréal began producing reconstructed skin in 2008, using several different technologies that rebuild human epidermis tissue from Asian keratinocytes. The reconstructed skin is used to test cosmetic products and ingredients for safety, eliminating the need for animal testing. The Chinese Episkin model is produced by the L’Oréal Advanced Research laboratories in China.